Taulant Muka1, Ester A L de Jonge1, Jessica C Kiefte-de Jong1, André G Uitterlinden1, Albert Hofman1, Abbas Dehghan1, M Carola Zillikens1, Oscar H Franco1, Fernando Rivadeneira1. 1. Departments of Epidemiology (T.M., E.A.L.d.J., J.C.K.-d.J., A.G.U., A.H., A.D., O.H.F., F.R.) and Internal Medicine (E.A.L.d.J., A.G.U., M.C.Z., F.R.), Erasmus Medical Center, Rotterdam CA 3000, The Netherlands; Netherlands Consortium for Healthy Ageing (A.G.U., A.H., A.D., M.C.Z., O.H.F., F.R.), Netherlands Genomics Initiative, The Hague 2593 CE, The Netherlands; and Leiden University College (J.C.K.-d.J.), The Hague 3595 DG, The Netherlands.
Abstract
CONTEXT: The role of uric acid (UA) in skeletal metabolism remains to be unraveled. OBJECTIVE: We prospectively investigated the association between UA, bone mineral density at the femoral neck (FN-BMD), hip bone geometry parameters, and incident fracture risk and examined whether the associations were modified by age and vitamin C intake. PARTICIPANTS AND SETTING: Data of 5074 participants of The Rotterdam Study, a prospective population-based cohort. EXPOSURE: Serum UA was assessed at baseline. MAIN OUTCOMES AND MEASURES: FN-BMD was measured at baseline, and at second, third, and fourth visits of the Rotterdam Study. Hip bone geometry parameters were measured at baseline and at the second and third visits. RESULTS: Serum UA levels (per SD increase) were positively associated with FN-BMD (β = 0.007 g/cm(2); 95% confidence interval [CI] = 0.002-0.01), thicker cortices (β = 0.002 cm; 95% CI = 0.0003-0.002), lower bone width (β = -0.013 cm; 95% CI = -0.23 to -0.003), and lower cortical buckling ratio (β = -0.19; 95% CI = -0.33 to -0.06). The effects of UA on FN-BMD and cortical buckling ratio tended to become stronger over time. Hazard ratios and 95% CIs per SD increase of baseline UA levels for the development of any type of incident fractures, nonvertebral fractures, and osteoporotic fractures were 0.932 (0.86-0.995), 0.924 (0.856-0.998), and 0.905 (0.849-0.982), respectively. These associations were more prominent in older individuals (age, >65 y) and in participants with high intakes of vitamin C (> median). CONCLUSIONS: Higher levels of serum UA are associated with higher BMD (at the expense of thicker cortices and narrower bone diameters) and may be a protective factor in bone metabolism. However, interactions with age and vitamin C may be present.
CONTEXT: The role of uric acid (UA) in skeletal metabolism remains to be unraveled. OBJECTIVE: We prospectively investigated the association between UA, bone mineral density at the femoral neck (FN-BMD), hip bone geometry parameters, and incident fracture risk and examined whether the associations were modified by age and vitamin C intake. PARTICIPANTS AND SETTING: Data of 5074 participants of The Rotterdam Study, a prospective population-based cohort. EXPOSURE: Serum UA was assessed at baseline. MAIN OUTCOMES AND MEASURES: FN-BMD was measured at baseline, and at second, third, and fourth visits of the Rotterdam Study. Hip bone geometry parameters were measured at baseline and at the second and third visits. RESULTS: Serum UA levels (per SD increase) were positively associated with FN-BMD (β = 0.007 g/cm(2); 95% confidence interval [CI] = 0.002-0.01), thicker cortices (β = 0.002 cm; 95% CI = 0.0003-0.002), lower bone width (β = -0.013 cm; 95% CI = -0.23 to -0.003), and lower cortical buckling ratio (β = -0.19; 95% CI = -0.33 to -0.06). The effects of UA on FN-BMD and cortical buckling ratio tended to become stronger over time. Hazard ratios and 95% CIs per SD increase of baseline UA levels for the development of any type of incident fractures, nonvertebral fractures, and osteoporotic fractures were 0.932 (0.86-0.995), 0.924 (0.856-0.998), and 0.905 (0.849-0.982), respectively. These associations were more prominent in older individuals (age, >65 y) and in participants with high intakes of vitamin C (> median). CONCLUSIONS: Higher levels of serum UA are associated with higher BMD (at the expense of thicker cortices and narrower bone diameters) and may be a protective factor in bone metabolism. However, interactions with age and vitamin C may be present.
Authors: Julie M Paik; Seoyoung C Kim; Diane Feskanich; Hyon K Choi; Daniel H Solomon; Gary C Curhan Journal: Arthritis Rheumatol Date: 2017-02 Impact factor: 10.995
Authors: M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman Journal: Eur J Epidemiol Date: 2017-10-24 Impact factor: 8.082
Authors: M Pirro; M R Mannarino; V Bianconi; S De Vuono; A Sahebkar; F Bagaglia; L Franceschini; A M Scarponi; E Mannarino; T Merriman Journal: Osteoporos Int Date: 2016-10-10 Impact factor: 4.507